Immutep said IMP761 was found safe in initial data from a Phase 1 trial, with no treatment-related adverse events reported.

Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, ...

About four in five adults with long-term stable MS who stopped first-line treatment with a DMT showed signs of disease ...

Columnist Desiree Lama has been living with MS for several years, yet she still appreciatea the advice and advocacy of her ...

Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough ...

Columnist Ahna Crum knows what MS has taken from her, but she also recognizes the significant gifts it's granted over the ...

A high genetic risk for MS, along with exposure to tobacco or other environmental factors, can affect early brain development ...

Two studies linked a type of lesions with chronic inflammation, paramagnetic rim lesions, with worse MS disability ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

Blood storage conditions, age, and other factors can influence the levels of NfL, a nerve damage biomarker used in MS ...

Columnist Leigh Anne Nelson has gone for the ride as she's been changing neurologists and nurse practitioners. But any change ...